Recent advances in improving the screening technology of leukemia cells have allowed medical researchers to deepen their understanding of the mechanisms that unfold at the time these cells develop in the patient's body. In particular, this helped the San Diego medical team to present a new approach to the treatment of a certain type of leukemia – acute myeloid leukemia, which is most active and dangerous in terms of disarming the immune system. This form of leukemia changes the forerunners of cells in the bone tissue, preventing them from developing into full-fledged white blood cells – thereby causing their accumulation and the occurrence of infections, which often result in internal hemorrhage.
However, the new approach of San Diego specialists revolves around the study of various patterns and characteristics that arise in stem cells and blood cells when exposed to certain drugs and substances – because they seek to establish how genes work in a population of cancer cells. Using the technology of rapid cell shielding, experts were able to collect many profiles of the effects of drugs and compounds on stem cells previously collected from patients suffering from acute myeloid leukemia – and the results were really interesting.
They managed to establish the presence of 12 medicinal compounds that very effectively fight leukemia cells and at the same time exert a strong influence on their reproduction and distribution mechanisms, essentially blocking this possibility – which allows specialists to more accurately and better control the course of the disease in patients. However, these results have a downside.
It lies in the fact that even though these 12 compounds found do have a positive effect on leukemia cells, they are not able, or almost unable to cope with carcinogens in individual cells, which indicates the need to refine the current configuration of the experiment. In any case, it remains to wait for the subsequent comments of the researchers.